Suppr超能文献

自体肾切除联合肾移植与常染色体显性多囊肾病患者降压药物需求减少相关。

Native Nephrectomy with Renal Transplantation is Associated with a Decrease in Hypertension Medication Requirements for Autosomal Dominant Polycystic Kidney Disease.

作者信息

Shumate Ashley M, Bahler Clinton D, Goggins William C, Sharfuddin Asif A, Sundaram Chandru P

机构信息

Department of Urology, Indiana University, Indianapolis, Indiana.

Department of Surgery, Indiana University, Indianapolis, Indiana.

出版信息

J Urol. 2016 Jan;195(1):141-6. doi: 10.1016/j.juro.2015.07.114. Epub 2015 Aug 28.

Abstract

PURPOSE

We assessed hypertensive control after native nephrectomy and renal transplantation in patients with autosomal dominant polycystic kidney disease.

MATERIALS AND METHODS

Blood pressure control was studied retrospectively in 118 patients with autosomal dominant polycystic kidney disease who underwent renal transplantation between 2003 and 2013. Overall 54 patients underwent transplantation alone (group 1) and 64 underwent transplantation with concurrent ipsilateral nephrectomy (group 2). Of these 64 patients 32 underwent ipsilateral nephrectomy only (group 2a) and 32 underwent eventual delayed contralateral native nephrectomy (group 2b). The number of antihypertensive drugs and defined daily dose of each antihypertensive was recorded at transplantation and up to 36-month followup.

RESULTS

Comparing preoperative to postoperative medications at 12, 24 and 36-month followup, transplantation with concurrent ipsilateral nephrectomy had a greater decrease in quantity (-1.2 vs -0.5 medications, p=0.008; -1.1 vs -0.3, p=0.007 and -1.2 vs -0.4, p=0.03, respectively) and defined daily dose of antihypertensive drug (-3.3 vs -1.0, p=0.0008; -2.9 vs -1.0, p=0.006 and -2.7 vs -0.6, p=0.007, respectively) than transplantation alone at each point. Native nephrectomy continued to be a predictor of hypertensive requirements on multivariable analysis (p <0.0001). The mean decrease in number of medications in group 2b from after ipsilateral nephrectomy to 12 months after contralateral nephrectomy was -0.6 (p=0.0005) and the mean decrease in defined daily dose was -0.6 (p=0.009).

CONCLUSIONS

In patients with autosomal dominant polycystic kidney disease undergoing renal transplantation, concurrent ipsilateral native nephrectomy is associated with a significant decrease in the quantity and defined daily dose of antihypertensive drugs needed for hypertension control. Delayed contralateral native nephrectomy is associated with improved control of blood pressure to an even greater degree.

摘要

目的

我们评估了常染色体显性多囊肾病患者在接受自体肾切除和肾移植后的高血压控制情况。

材料与方法

对2003年至2013年间接受肾移植的118例常染色体显性多囊肾病患者的血压控制情况进行了回顾性研究。总共有54例患者仅接受了移植手术(第1组),64例患者在移植的同时接受了同侧肾切除术(第2组)。在这64例患者中,32例仅接受了同侧肾切除术(第2a组),32例最终接受了延迟的对侧自体肾切除术(第2b组)。记录了移植时以及长达36个月随访期间的抗高血压药物数量和每种抗高血压药物的限定日剂量。

结果

在12个月、24个月和36个月随访时比较术前和术后用药情况,移植时同时进行同侧肾切除术的患者在药物数量(分别为-1.2对-0.5种药物,p = 0.008;-1.1对-0.3,p = 0.007;-1.2对-0.4,p = 0.03)和抗高血压药物的限定日剂量(分别为-3.3对-1.0,p = 0.0008;-2.9对-1.0,p = 0.006;-2.7对-0.6,p = 0.007)方面的下降幅度均大于仅接受移植手术的患者。在多变量分析中,自体肾切除术仍然是高血压治疗需求的一个预测因素(p <0.0001)。第2b组从同侧肾切除术后到对侧肾切除术后12个月,药物数量的平均减少量为-0.6(p = 0.0005),限定日剂量的平均减少量为-0.6(p = 0.009)。

结论

在接受肾移植的常染色体显性多囊肾病患者中,同时进行同侧自体肾切除术与控制高血压所需的抗高血压药物数量和限定日剂量显著减少相关。延迟进行对侧自体肾切除术与血压控制的进一步改善相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验